126 related articles for article (PubMed ID: 37672543)
21. Abrogated cryptic activation of lentiviral transfer vectors.
Luche RM; Enssle J; Kiem HP
Sci Rep; 2012; 2():438. PubMed ID: 22666541
[TBL] [Abstract][Full Text] [Related]
22. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
23. Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies.
Parker CL; Jacobs TM; Huckaby JT; Harit D; Lai SK
mBio; 2020 Jan; 11(1):. PubMed ID: 31964730
[TBL] [Abstract][Full Text] [Related]
24. Cancer Gene Therapy: Development and Production of Lentiviral Vectors for Gene Therapy.
Coroadinha AS
Methods Mol Biol; 2022; 2521():297-315. PubMed ID: 35733005
[TBL] [Abstract][Full Text] [Related]
25. Design and construction of a recombinant lentiviral vector with specific tropism to human epidermal growth factor-overexpressed cancer cells: Developing a new retargeting system for lentivirus vectors.
Ebrahimabadi S; Shahbazi M; Akbari M; Golalipour M; Farazmandfar T
J Gene Med; 2019 Jun; 21(6):e3095. PubMed ID: 31050357
[TBL] [Abstract][Full Text] [Related]
26. A multigene lentiviral vector system based on differential splicing.
Zhu Y; Planelles V
Methods Mol Med; 2003; 76():433-48. PubMed ID: 12526178
[No Abstract] [Full Text] [Related]
27. [Inhibition of HIV-1 in vitro by combination of vpr and tat specific short hairpin RNA via lentiviral vectors].
Hao YZ; Teng ZP; Yang YS; Sun XN; Ma J; Jin XH; Zeng Y
Bing Du Xue Bao; 2013 Mar; 29(2):126-31. PubMed ID: 23757841
[TBL] [Abstract][Full Text] [Related]
28. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
29. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
[TBL] [Abstract][Full Text] [Related]
30. Design of a trans protease lentiviral packaging system that produces high titer virus.
Westerman KA; Ao Z; Cohen EA; Leboulch P
Retrovirology; 2007 Dec; 4():96. PubMed ID: 18163907
[TBL] [Abstract][Full Text] [Related]
31. Construction of stable packaging cell lines for clinical lentiviral vector production.
Sanber KS; Knight SB; Stephen SL; Bailey R; Escors D; Minshull J; Santilli G; Thrasher AJ; Collins MK; Takeuchi Y
Sci Rep; 2015 Mar; 5():9021. PubMed ID: 25762005
[TBL] [Abstract][Full Text] [Related]
32. Improved third-generation lentiviral packaging with pLKO.1C vectors.
Lee S; Cobrinik D
Biotechniques; 2020 Jun; 68(6):349-352. PubMed ID: 32141762
[TBL] [Abstract][Full Text] [Related]
33. The Engineered MARCH8-Resistant Vesicular Stomatitis Virus Glycoprotein Enhances Lentiviral Vector Transduction.
Xu F; Liu X; Zhang D; Zhao F; Fan Z; Hu S; Mei S; Huang Y; Sun H; Wei L; Guo L; Wang J; Cen S; Liang C; Guo F
Hum Gene Ther; 2021 Sep; 32(17-18):936-948. PubMed ID: 33678011
[TBL] [Abstract][Full Text] [Related]
34. Lentiviral vectors: optimization of packaging, transduction and gene expression.
Delenda C
J Gene Med; 2004 Feb; 6 Suppl 1():S125-38. PubMed ID: 14978756
[TBL] [Abstract][Full Text] [Related]
35. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
[TBL] [Abstract][Full Text] [Related]
36. Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectors.
Johnson S; Wheeler JX; Thorpe R; Collins M; Takeuchi Y; Zhao Y
Biologicals; 2018 Mar; 52():59-66. PubMed ID: 29361371
[TBL] [Abstract][Full Text] [Related]
37. β-Globin Lentiviral Vectors Have Reduced Titers due to Incomplete Vector RNA Genomes and Lowered Virion Production.
Han J; Tam K; Ma F; Tam C; Aleshe B; Wang X; Quintos JP; Morselli M; Pellegrini M; Hollis RP; Kohn DB
Stem Cell Reports; 2021 Jan; 16(1):198-211. PubMed ID: 33186538
[TBL] [Abstract][Full Text] [Related]
38. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
[TBL] [Abstract][Full Text] [Related]
39. Development of Lentiviral Vectors for Targeted Integration and Protein Delivery.
Schenkwein D; Ylä-Herttuala S
Methods Mol Biol; 2016; 1448():185-98. PubMed ID: 27317182
[TBL] [Abstract][Full Text] [Related]
40. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.
Kim VN; Mitrophanous K; Kingsman SM; Kingsman AJ
J Virol; 1998 Jan; 72(1):811-6. PubMed ID: 9420292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
